Contineum Therapeutics Inc (CTNM) Implied Volatility Current

Tracking CTNM implied volatility helps you identify when options premiums on Contineum Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Contineum Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when CTNM IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Contineum Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CTNM, tracking metrics like CTNM IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CTNM signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist.

Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CTNM implied volatility sits today versus where it has been. Our scanner ranks Contineum Therapeutics Inc implied volatility against its historical range, surfaces extremes in CTNM IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Contineum Therapeutics Inc IV is rich or cheap — measure it, then act on it.